Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)

Pharmaceutical Research

Volumn 16, Issue 10, 1999, Pages 1550-1556

  Dintaman, Jay M ^a   Silverman, Jeffrey A ^a  

^a AvMax Inc   (United States)

Author keywords

Bioavailability; Drug transport; P glycoprotein; TPGS

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; COLCHICINE; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; MACROGOL DERIVATIVE; PACLITAXEL; VINBLASTINE;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG UPTAKE; EMBRYO; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CELL SURVIVAL; COLORING AGENTS; CYCLOSPORINE; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENTS; MICE; MICELLES; P-GLYCOPROTEIN; PACLITAXEL; POLYETHYLENE GLYCOLS; RHODAMINE 123; VINBLASTINE; VITAMIN E;

EID: 0032714228     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015000503629     Document Type: Article

References (44)

1. L. J. Goldstein. MDRI gene expression in solid tumors. Eur. J. Cancer. 32A:1039-1050 (1996).
2. J. A. Endicott and V. Ling. The biochemistry of P-glycoprotein mediated multidrug resistance. Ann. Rev. Biochem. 58:137-171 (1989).
3. M. M. Gottesman. How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal foundation award lecture. Cancer Res. 53:747-754 (1993).
4. M. M. Gottesman and I. Pastan. The multidrug transporter, a double edged sword, J. Biol. Chem. 263:12163-12166 (1988).
5. M. M. Gottesman and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62:385-427 (1993).
6. S.S. Thorgeirsson, J. A. Silverman, T. W. Gant, and P. A. Marino. Multidrug resistance gene family and chemical carcinogens. Pharmacol. Ther. 49:283-292 (1991).
7. P. Borst, A. H. Schinkel, J. J. M. Smit, E. Wagenaar, L. Van Deemter, A. J. Smith, W. H. M. Eijdems, F. Baas, and G. J. R. Zaman. Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol. Ther. 60:289-299 (1993).
8. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84:7735-7738 (1987).
9. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity on one antibody with a muscle protein. J. Histochem. Cytochem. 37:159-164 (1989).
10. B. L. Lum and M. P. Gosland. MDR expression in normal tissues. Hematol. Oncol. North Am. 9:319-336 (1995).
11. A. H. Schinkel, J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502 (1994).
12. J. van Asperen, O. van Tellingen, A. Sparreboom, A. H. Schinkel, P. Borst, W. J. Nooijen, and J. H. Beijnen. Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. Br. J. Cancer 76:1181-1183 (1997).
13. J. van Asperen, A. H. Schinkel, J. H. Beijnen, W. J. Nooijen, P. Borst, and O. van Tellingen. Altered pharmacokinetics of vinblastine in mdrla P-glycoprotein-deficient mice. J. Natl. Cancer Inst. 88:994-999 (1996).
14. A. H. Schinkel, U. Mayer, E. Wagenaar, C. A. A. M. Mol, L. van Deemter, J. J. M. Smit, M. A. van der Valk, A. C. Voordouw, H. Spits, O. van Tellingen, J. M. J. M. Zijlmans, W. E. Fibbe, and P. Borst. Normal viability and altered pharmacokinetics in mice lacking mdrl -type (drug transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94:4028-4033 (1997).
15. S. -F. Su and J. -D. Huang. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metab. Dispos. 24:142-147 (1996).
16. B. -L. Leu and J. -ding Huang. Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother. Pharmacol. 35:432-436 (1995).
17. V.J. Wacher, C. -Y. Wu, and L. Z. Benet. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol. Carcin. 13:129-134 (1995).
18. V. J. Wacher, L. Salphati, and L. Z. Benet. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Del. Rev. 20:99-112 (1996).
19. V. J. Wacher, J. A. Silverman, Y. Zhang, and L. Z. Benet. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J. Pharm. Sci. 87:1322-1330 (1998).
20. J. P. Boudreaux, D. H. Hayes, S. Mizrahi, P. Maggiore, J. Blazek, and D. Dick. Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. Transplant. Proc. 25:1875 (1993).
21. R. J. Sokol, K. E. Johnson, F. M. Karrer, M. R. Narkewicz, D. Smith, and I. Kam. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet. 338:212-215 (1991).
22. T. Chang. L. Z. Benet, and M. F. Hebert. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin. Pharmacol. Ther. 59:1-7 (1996).
23. C. O. Cardarelli, I. Aksentijevich, I. Pastan, and M. M. Gottesman. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res. 55:1086-1091 (1995).
24. T. Mosmann. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63 (1983).
25. M. B. Hansen, S. E. Nielsen, and K. Berg. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203-210 (1989).
26. J. Hunter, B. H. Hirst, and N. L. Simmons. Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein. Br. J. Cancer 64:437-444 (1991).
27. A. E. Kim, J. M. Dintaman, D. S. Waddell, and J. A. Silverman. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. J. Pharmacol. Exp. Ther. 286:1439-1445 (1998).
28. T. W. Gant. J. A. Silverman, H. C. Bisgaard, R. K. Burt, P. A. Marino, and S. S. Thorgeirsson. Regulation of 2-acetylaminofluorene and 3-methylcholanthrene mediated induction of mdr and cytochrome P4501A gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcin. 4:499-509 (1991).
29. E. Georges, G. Bradley, J. Gariepy, and V. Ling. Detection of P-glycoprotein isoforms by gene specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:152-156 (1990).
30. S. J. Currier, S. E. Kane, M. C. Willingham, C. O. Cardarelli, I. Pastan, and M. M. Gottesman. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. J. Biol. Chem. 267:25153-25159 (1992).
31. E. Santoni-Rugiu and J. A. Silverman. Functional characterization of the rat mdrlb encoded P-glycoprotein: not all inducing agents are substrates. Carcinogenesis 18:2255-2263 (1997).
32. S.V. Egudina, T. P. Stromskaya, E. A. Frolova, and A. A. Stravrovskaya. Early steps of the P-glycoprotein in cell cultures studied with vital fluorchrome. FEBS Lett. 329:63-66 (1993).
33. P.M. Chaudhary, E. B. Metchener, and I. B. Roninson. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735-2739 (1992).
34. J. Hunter, M. A. Jepson, T. Tsuruo, N. L. Simmons, and B. H. Hirst. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. J. Biol. Chem. 268:14991-14997 (1993).
35. P. Artursson. Epithelial transport of drugs in cell culture.I: A model for studying the passive diffusion of drugs over intestinal absorbtive (Caco-2) cells. J. Pharm. Sci. 79:476-482 (1990).
36. K. L. Audus, R. L. Bartel, I. J. Hidalgo, and R. T. Borchardt. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm. Res. 7:435-451 (1990).
37. G. H. Mickisch, G. T. Merlino, H. Galski, M. M. Gottesman, and I. Pastan. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc. Natl. Acad. Sci. USA 88:547-551 (1991).
38. M. M. Nerurkar, P. S. Burton, and R. T. Borchardt. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm. Res. 13:528-534 (1996).
39. D. S. Chervinsky, M. L. Brecher, and M. J. Hoelcle. Cremophor-EL enhances taxol efficacy in a multi-drug resistan C1300 neuroblastoma cell line. Anticancer Res. 13:93-96 (1993).
40. L. E. Buckingham, M. Balasuramanian, R. M. Emanuele, K. E. Clodfelter, and J. S. Coon. Comparison of Solutol HS15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents. Int. J. Cancer 62:436-442 (1995).
41. D. M. Woodcock, S. Jefferson, M. E. Linsenmeyer, P. J. Crowther, G. M. Chojnowski. B. Williams, and I. Bertoncello. Reversal of the multidrug resistance phenotype with Cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res. 50:4199-4203 (1990).
42. L. Webster, M. Linsenmeyer, M. Millward, C. Morton, J. Bishop, and D. Woodcock. Measurement of cremophor-el following taxol: Plasma levels sufficient to reverse drug exclusion mediated by the multidrug resistant phenotype. J. Natl. Cancer Inst. 85:1685-1690 (1993).
43. E. V. Batrakova, H. Y. Han, D. W. Miller, and A. V. Kabanov. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. 15:1525-1532 (1998).
44. S. H. Pan, R. R. J. Lopez, L. S. Sher, A. L. Hoffman, L. G. Podesta, L. Makowaka, and P. Rosenthal. Enhanced oral cyclosporine absorption with water-soluble vitamine E early after liver transplantation. Pharmacother. 16:59-65 (1996).